Recent Press Releases

Panadol® Advance 100 ct Product Recall in Puerto Rico

Panadol® Advance 100 ct Product Recall in Puerto Rico Guaynabo, PR. – July 9, 2014 – GlaxoSmithKline (GSK) Consumer Healthcare is voluntarily recalling all Panadol® Advance 100 ct...

APTUIT NAMES DR. PAUL OVERTON EXECUTIVE VP, BUSINESS DEVELOPMENT & MARKETING; ENHANCES STERILE DRUG PRODUCT CAPABILITIES

APTUIT NAMES DR. PAUL OVERTON EXECUTIVE VP, BUSINESS DEVELOPMENT & MARKETING; ENHANCES STERILE DRUG PRODUCT CAPABILITIES Greenwich, CT, July 15, 2014 -- Aptuit LLC has appointed Paul D. Overton,...

West Dedicates Pharmaceutical Manufacturing Plant in India

Chennai, India – July 16, 2014 –West Pharmaceutical Services, Inc. (NYSE: WST) has dedicated its manufacturing plant in the Sri City Special Economic Zone (SEZ), where the company will...

GSK begins shipping 2014-15 U.S. flu vaccines

GSK begins shipping 2014-15 U.S. flu vaccines Expected 28 - 33 million doses of four-strain and three-strain flu shots will help meet U.S. public health needs GSK [LSE/NYSE: GSK] announced today it...

Sun Pharma acquires Pharmalucence

Sun Pharma acquires Pharmalucence Mumbai, July 16, 2014: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced acquisition of...

KBR to Construct Oral Solid Dosage Production Facility for Purdue Pharma Manufacturing L.P. in Durham, N.C.

KBR to Construct Oral Solid Dosage Production Facility for Purdue Pharma Manufacturing L.P. in Durham, N.C. (Thomson Reuters ONE via COMTEX) -- HOUSTON - July 9, 2014 -- KBR KBR +1.26% announced...

Hospira Issues Voluntary Nationwide Recall Of One Lot Of Lactated Ringers And 5% Dextrose Injection, Usp, 1000 ML, Flexible Containers Due To Mold Contamination

FOR IMMEDIATE RELEASE - July 10, 2014 - Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary nationwide user-level recall of one lot of Lactated Ringers and 5% Dextrose Injection,...

Codexis Announces Technology Collaboration and License Agreement with GSK

Codexis Announces Technology Collaboration and License Agreement with GSK Codexis to Receive up to $25 Million of Initial Payments, Plus Additional Milestone and Royalty Opportunities Codexis...

Biopharmaceutical Research and Manufacturing Sector on U.S. Court of Appeals Oral Arguments Against Alameda Ordinance

Biopharmaceutical Research and Manufacturing Sector on U.S. Court of Appeals Oral Arguments Against Alameda Ordinance Washington, D.C. (July 11, 2014) Today, counsel for the Pharmaceutical Research...

Waters and Chinese Pharmacopeia Commission Signed Joint Open Laboratory Cooperation Agreement

Waters and Chinese Pharmacopeia Commission Signed Joint Open Laboratory Cooperation Agreement MILFORD, Mass.--(BUSINESS WIRE)--July 09, 2014-- Waters Corporation (NYSE: WAT) today announced an...

The Cancer Immunotherapy Market Will Increase to Nearly $9 Billion Across the World's Major Pharmaceutical Markets In 2022

Immune Checkpoint Inhibitors Will Hold an Impressive 85 Percent Market Share, According to Findings from Decision Resources Group June 30, 2014 - Burlington, Mass. – Decision Resources Group...

£14.4m Investment into Formulation Innovation Centre

£14.4m Investment into Formulation Innovation Centre The North East Local Enterprise Partnership has announced an investment of £7.4m into The Centre for Process Innovation (CPI) to...

Xellia Pharmaceuticals Expands into the US with Acquisition of Manufacturing Plant

Xellia Pharmaceuticals Expands into the US with Acquisition of Manufacturing Plant COPENHAGEN, Jul 07, 2014 (BUSINESS WIRE) -- Xellia Pharmaceuticals ('Xellia'), a specialty pharmaceutical...

Medicure Acquires Minority Position in Pharmaceutical Manufacturer, Apicore

Medicure Acquires Minority Position in Pharmaceutical Manufacturer, Apicore WINNIPEG, MANITOBA--(Marketwired - July 3, 2014) - Medicure Inc. ("Medicure" or the "Company") (TSX...

Hospira Completes Acquisition of Orchid's Active Pharmaceutical Ingredient Manufacturing and R&D Facility

Hospira Completes Acquisition of Orchid's Active Pharmaceutical Ingredient Manufacturing and R&D Facility -- Purchase enhances cost-competitiveness, paves way for future development -- LAKE...

Dogs Merck Animal Health Announces FDA Approval of BRAVECTO™ (fluralaner)

First Chewable Tablet for Dogs Effective for 12 Weeks* Against Fleas and Ticks SUMMIT, NJ, May 20, 2014 – Merck Animal Health (known as MSD Animal Health outside the United States and Canada)...

Equinext and Centaur Animal Health Enter Distribution Agreement for Innovative Equine Medical Device Novobrace

Novobrace, an injectable bioadhesive, stabilizes equine tendon and ligament injuries, including tendonitis. LEXINGTON, Ky., OLATHE, Kan. and PHILADELPHIA, June 27, 2014 -- Equinext and Centaur...

CMC Biologics Enters into Commercial Supply Agreement with Portola Pharmaceuticals for Manufacturing of First-In-Class Factor Xa Inhibitor Antidote Andexanet Alfa

CMC Biologics Enters into Commercial Supply Agreement with Portola Pharmaceuticals for Manufacturing of First-In-Class Factor Xa Inhibitor Antidote Andexanet Alfa SEATTLE, July 2, 2014 /PRNewswire/...

Recipharm and Pharmanest form collaboration for commercial manufacture and supply of SHACT

Recipharm and Pharmanest form collaboration for commercial manufacture and supply of SHACT 03 July 2014: Recipharm Karlskoga AB, specialized in the manufacture of semi-solid products, and...

AMRI Completes Acquisition of Oso Biopharmaceuticals Manufacturing

AMRI Completes Acquisition of Oso Biopharmaceuticals Manufacturing ALBANY, N.Y., July 1, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Oso...